Paroxysmal nocturnal is an uncommon and life-threatening blood disorder. Hemolytic anemia (red blood cell destruction), blood clots (thrombosis), and reduced bone marrow function are all symptoms of the condition (not making enough of the three blood components). Paroxysmal is a condition that primarily affects young individuals and affects 1-1.5 people per million. The average age of diagnosis is 35-40 years old, with some cases being diagnosed as early as childhood or adolescence.
Aplastic anemia and Paroxysmal nocturnal are tightly linked. Aplastic anemia is the cause of up to 30% of newly diagnosed cases of Paroxysmal . Similarly, after using immunosuppressive drugs for aplastic anemia (anti-thymocyte globulin and cyclosporine), the risk of getting Paroxysmal nocturnal syndrome is about 20-30%. After a diagnosis, the typical survival time is ten years; however, some people might live for decades with just modest symptoms.